ゼリア新薬工業の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2012/01/12 | 1,346 | 1,360 | 1,300 | 1,351 | -7 | -0.5% | 33,000 |
| 2012/01/11 | 1,375 | 1,375 | 1,358 | 1,358 | -15 | -1.1% | 4,000 |
| 2012/01/10 | 1,350 | 1,376 | 1,350 | 1,373 | +23 | +1.7% | 20,000 |
| 2012/01/06 | 1,340 | 1,360 | 1,340 | 1,350 | +10 | +0.7% | 25,000 |
| 2012/01/05 | 1,349 | 1,349 | 1,340 | 1,340 | -5 | -0.4% | 10,000 |
| 2012/01/04 | 1,330 | 1,345 | 1,318 | 1,345 | +16 | +1.2% | 18,000 |
| 2011/12/30 | 1,326 | 1,329 | 1,312 | 1,329 | +3 | +0.2% | 14,000 |
| 2011/12/29 | 1,303 | 1,326 | 1,281 | 1,326 | +23 | +1.8% | 9,000 |
| 2011/12/28 | 1,318 | 1,318 | 1,300 | 1,303 | -8 | -0.6% | 9,000 |
| 2011/12/27 | 1,319 | 1,319 | 1,310 | 1,311 | -7 | -0.5% | 3,000 |
| 2011/12/26 | 1,315 | 1,330 | 1,303 | 1,318 | +12 | +0.9% | 16,000 |
| 2011/12/22 | 1,303 | 1,315 | 1,301 | 1,306 | +36 | +2.8% | 39,000 |
| 2011/12/21 | 1,276 | 1,276 | 1,270 | 1,270 | -5 | -0.4% | 2,000 |
| 2011/12/20 | 1,271 | 1,275 | 1,262 | 1,275 | +4 | +0.3% | 11,000 |
| 2011/12/19 | 1,302 | 1,302 | 1,267 | 1,271 | -14 | -1.1% | 14,000 |
| 2011/12/16 | 1,314 | 1,314 | 1,285 | 1,285 | -13 | -1% | 12,000 |
| 2011/12/15 | 1,304 | 1,304 | 1,283 | 1,298 | -13 | -1% | 10,000 |
| 2011/12/14 | 1,315 | 1,319 | 1,303 | 1,311 | -5 | -0.4% | 19,000 |
| 2011/12/13 | 1,309 | 1,316 | 1,300 | 1,316 | +14 | +1.1% | 15,000 |
| 2011/12/12 | 1,316 | 1,317 | 1,289 | 1,302 | -8 | -0.6% | 17,000 |
| 2011/12/09 | 1,301 | 1,310 | 1,296 | 1,310 | +39 | +3.1% | 69,000 |
| 2011/12/08 | 1,295 | 1,300 | 1,270 | 1,271 | -27 | -2.1% | 11,000 |
| 2011/12/07 | 1,282 | 1,298 | 1,273 | 1,298 | +39 | +3.1% | 17,000 |
| 2011/12/06 | 1,278 | 1,278 | 1,258 | 1,259 | -19 | -1.5% | 9,000 |
| 2011/12/05 | 1,270 | 1,283 | 1,270 | 1,278 | +10 | +0.8% | 6,000 |
| 2011/12/02 | 1,254 | 1,268 | 1,240 | 1,268 | +36 | +2.9% | 11,000 |
| 2011/12/01 | 1,254 | 1,254 | 1,222 | 1,232 | +8 | +0.7% | 6,000 |
| 2011/11/30 | 1,220 | 1,250 | 1,218 | 1,224 | -23 | -1.8% | 14,000 |
| 2011/11/29 | 1,221 | 1,247 | 1,216 | 1,247 | +26 | +2.1% | 11,000 |
| 2011/11/28 | 1,260 | 1,290 | 1,214 | 1,221 | -25 | -2% | 19,000 |
| 2011/11/25 | 1,206 | 1,246 | 1,206 | 1,246 | +40 | +3.3% | 8,000 |
| 2011/11/24 | 1,224 | 1,224 | 1,195 | 1,206 | -18 | -1.5% | 9,000 |
| 2011/11/22 | 1,201 | 1,224 | 1,201 | 1,224 | -2 | -0.2% | 7,000 |
| 2011/11/21 | 1,221 | 1,249 | 1,219 | 1,226 | +5 | +0.4% | 8,000 |
| 2011/11/18 | 1,173 | 1,241 | 1,171 | 1,221 | +30 | +2.5% | 29,000 |
| 2011/11/17 | 1,183 | 1,192 | 1,182 | 1,191 | -22 | -1.8% | 19,000 |
| 2011/11/16 | 1,195 | 1,213 | 1,189 | 1,213 | -1 | -0.1% | 3,000 |
| 2011/11/15 | 1,185 | 1,214 | 1,180 | 1,214 | +29 | +2.4% | 8,000 |
| 2011/11/14 | 1,195 | 1,195 | 1,182 | 1,185 | -30 | -2.5% | 13,000 |
| 2011/11/11 | 1,206 | 1,218 | 1,203 | 1,215 | -20 | -1.6% | 14,000 |
| 2011/11/10 | 1,233 | 1,241 | 1,221 | 1,235 | -28 | -2.2% | 11,000 |
| 2011/11/09 | 1,227 | 1,263 | 1,208 | 1,263 | +66 | +5.5% | 27,000 |
| 2011/11/08 | 1,214 | 1,215 | 1,197 | 1,197 | -17 | -1.4% | 7,000 |
| 2011/11/07 | 1,195 | 1,214 | 1,190 | 1,214 | -6 | -0.5% | 9,000 |
| 2011/11/04 | 1,233 | 1,233 | 1,220 | 1,220 | -4 | -0.3% | 4,000 |
| 2011/11/02 | 1,209 | 1,224 | 1,209 | 1,224 | -25 | -2% | 16,000 |
| 2011/11/01 | 1,268 | 1,268 | 1,230 | 1,249 | -49 | -3.8% | 22,000 |
| 2011/10/31 | 1,324 | 1,326 | 1,298 | 1,298 | -28 | -2.1% | 42,000 |
| 2011/10/28 | 1,264 | 1,336 | 1,249 | 1,326 | +92 | +7.5% | 70,000 |
| 2011/10/27 | 1,218 | 1,234 | 1,185 | 1,234 | +37 | +3.1% | 20,000 |
3151～
3200
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「ゼリア新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ゼリア新薬 | 224,400円 | +13.6% | +29.2% | 2.05% | 11.64倍 | 1.12倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| 鳥居薬 | 476,000円 | +12.0% | +28.1% | 2.52% | 26.24倍 | 1.11倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| 持田薬 | 331,500円 | +3.0% | +27.5% | 2.41% | 20.99倍 | 0.91倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| ネクセラファーマ | 113,200円 | +197.7% | - | 0.00% | 46.26倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
| 杏林製薬 | 149,900円 | +3.2% | +4.5% | 3.47% | 17.22倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム
